-
-
表 1 HER2免疫组化检测结果HercepTest评分系统[1]
表 2 34例乳腺癌标本应用手工与机器染色ER和PR
表 3 32例乳腺癌标本应用手工与机器染色HER2
-
[1] Mayr D, Heim S, Werhan C, et al. Comprehensive immunohistochemical analysis of Her-2/neu oncoprotein overexpression in breast cancer:HercepTest (Dako) for manual testing and Her-2/neuTest 4B5(Ventana) for Ventana BenchMark automatic staining system with correlation to results of fluorescence in situ hybridization (FISH)[J]. Virchows Arch, 2009, 454:241-248. doi: 10.1007/s00428-009-0728-8 [2] Tagliabue E, Balsari A, Campiglio M, et al. HER2 as a target for breast cancer therapy[J]. Expert Opin Biol Ther, 2010, 10:711-724. doi: 10.1517/14712591003689972 [3] Jacobs TW, Gown AM, Yaziji H, et al. Specificity of hercep Test in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system[J]. J Clin Oncol, 1999, 17:1983-1987. doi: 10.1200/JCO.1999.17.7.1983